Clinical Research Directory
Browse clinical research sites, groups, and studies.
Extending Time Without Diabetes After Bariatric Surgery: a Trial Comparing the Metformin Addition or Not to Standard Care
Sponsor: Assistance Publique - Hôpitaux de Paris
Summary
This study is a randomized trial that evaluates the effect of metformin addition or not to standard care on the duration of diabetes remission after bariatric surgery.
Official title: Extending Time Without Diabetes After Bariatric Surgery: a Randomized Controlled Trial Comparing the Metformin Addition or Not to Standard Care
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
126
Start Date
2021-01-07
Completion Date
2026-11
Last Updated
2023-06-08
Healthy Volunteers
No
Conditions
Interventions
Metformin
Metformin will start at dose of 850 mg once daily and, at one month increased to 850 mg twice daily
Standard Care
Standard Care
Standardized meal
Measurements of metformin-induced enterohormones secretion will be done after standardized meal test in a subgroup of patients (ancillary study)
Locations (16)
CHU Amiens-Picardie - hôpital Nord
Amiens, France
AP-HP - hôpital Avicenne
Bobigny, France
CHU de Bordeaux - hôpital Haut-Lévêque
Bordeaux, France
AP-HP - hôpital Ambroise-Paré
Boulogne-Billancourt, France
AP-HP - hôpital Louis-Mourier
Colombes, France
Centre hospitalier intercommunal de Créteil
Créteil, France
CHU de Lille - hôpital Claude Huriez
Lille, France
AP-HM - hôpital de la Conception
Marseille, France
AP-HM - hôpital Nord
Marseille, France
AP-HP - hôpital européen Georges-Pompidou
Paris, France
AP-HP - hôpital Bichat-Claude Bernard
Paris, France
AP-HP - hôpital de la Pitié-Salpêtrière
Paris, France
Institut Mutualiste Montsouris
Paris, France
HCL - centre hospitalier Lyon-Sud
Pierre-Bénite, France
CH de Saint-Denis - hôpital Delafontaire
Saint-Denis, France
CHU de Toulouse - hôpital Larrey
Toulouse, France